Determination of citalopram and escitalopram together with their active main metabolites desmethyl(es-)citalopram in human serum by column-switching high performance liquid chromatography (HPLC) and spectrophotometric detection

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 848, Issue 2, 2007, Pages 391-394

  Greiner, Christine ^a   Hiemke, Christoph ^a   Bader, Wolfgang ^a   Haen, Ekkehard ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Citalopram; Escitalopram; HPLC column switching; Quantitative analysis; TDM

Indexed keywords

CITALOPRAM; ESCITALOPRAM; HPLC COLUMN SWITCHING; ULTRAVIOLET SPECTROPHOTOMETRY;

ACETONITRILE; BODY FLUIDS; CHEMICAL ANALYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; METABOLITES; PH EFFECTS; PHOSPHATES; SPECTROPHOTOMETRY;

DRUG PRODUCTS;

ACETONITRILE; BUFFER; CITALOPRAM; DESMETHYLESCITALOPRAM; DRUG METABOLITE; ESCITALOPRAM; HALOPERIDOL; LU 26054; NORCITALOPRAM; PHOSPHATE; UNCLASSIFIED DRUG;

ARTICLE; AUTOANALYSIS; DRUG DETERMINATION; DRUG MONITORING; ELUTION; FLOW RATE; FLUID FLOW; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; QUANTITATIVE ASSAY; ULTRAVIOLET SPECTROPHOTOMETRY;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CITALOPRAM; HUMANS; REPRODUCIBILITY OF RESULTS; SPECTROPHOTOMETRY, ULTRAVIOLET; STEREOISOMERISM;

EID: 33947392467     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchromb.2006.10.058     Document Type: Article

References (13)

1. Popik P. J. Clin. Psychopharmacol. 19 5 Suppl. 1 (1999) 4
2. Bjerkenstedt L., Flyckt L., Overo K.F., and Lingjaerde O. Eur. J. Clin. Pharmacol. 28 5 (1985) 553
3. ®, March 2006.
4. Reis M., Olsson G., Carlsson B., Lundmark J., Dahl M.L., Walinder J., Ahlner J., and Bengtsson F. J. Clin. Psychopharmacol. 22 4 (2002) 406
5. Baumann P., Hiemke C., Ulrich S., Eckermann G., et al. Pharmacopsychiatry 37 (2004) 243
6. Akerman K.K., Jolkkonen J., Huttunen H., and Penttila I. Ther. Drug Monit. 20 1 (1998) 25
7. Macek J., Ptacek P., and Klima J. J. Chromatogr. B Biomed. Sci. Appl. 755 1-2 (2001) 279
8. Tournel G., Houdret N., Hedouin V., Deveau M., Gosset D., and Lhermitte M. J. Chromatogr. B Biomed. Sci. Appl. 761 2 (2001) 147
9. Waschgler R., Hubmann M.R., Conca A., Moll W., and Konig P. Int. J. Clin. Pharmacol. Ther. 40 12 (2002) 554
10. Kristoffersen L., Bugge A., Lundanes E., and Slordal L. J. Chromatogr. B Biomed. Sci. Appl. 734 2 (1999) 229
11. Titier K., Castaing N., Scotto-Gomez E., Pehourcq F., Moore N., and Molimard M. Ther. Drug Monit. 25 5 (2003) 581
12. Duverneuil C., de la Grandmaison G.L., de Mazancourt P., and Alvarez J.C. Ther. Drug Monit. 25 5 (2003) 565
13. ICH expert working group: Q2(R1): validation of analytical procedures: text and methodology, published in the Federal Register, vol. 60, 1995, pages 11260.